gamma-Interferon in multiple myeloma: inhibition of interleukin-6 (IL- 6)-dependent myeloma cell growth and downregulation of IL-6-receptor expression in vitro
Data up to Jan 2025
Total Citations Per Year
Abstract
References (28)
A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival
1975 • 3,051 citations
Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
1988 • 1,698 citations
IL-6 is produced by osteoblasts and induces bone resorption.
1990 • 1,121 citations
Cloning and Expression of the Human Interleukin-6 (BSF-2/IFNβ 2) Receptor
1988 • 1,063 citations
Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6
1989 • 775 citations
Immune interferon: a pleiotropic lymphokine with multiple effects
1985 • 676 citations
Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias.
1989 • 501 citations
Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia
1991 • 419 citations
Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma
1989 • 271 citations
Pretreatment tumor mass, cell kinetics, and prognosis in multiple myeloma
1980 • 269 citations
Response patterns of purified myeloma cells to hematopoietic growth factors
1989 • 231 citations
Recombinant human interferon-gamma inhibits formation of human osteoclast-like cells.
1986 • 187 citations
Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patients.
1985 • 185 citations
Interleukin-6 is a prognostic factor in multiple myeloma [letter] [see comments]
1991 • 145 citations
The growth fraction of human myeloma cells
1981 • 139 citations
Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma.
1990 • 124 citations
Enzymatic activity of the conserved core of a group I self-splicing intron
1986 • 114 citations
In vivo interleukin 6 gene expression in the tumoral environment in multiple myeloma
1991 • 91 citations
Interferon‐γ binds to heparan sulfate by a cluster of amino acids located in the C‐terminal part of the molecule
1991 • 81 citations
Interleukin-4 inhibits growth of multiple myelomas by suppressing interleukin-6 expression.
1991 • 65 citations
Recombinant interferon gamma in hairy cell leukemia, multiple myeloma, and Waldenstrom's macroglobulinemia
1988 • 55 citations
Interleukin-4 inhibits growth of multiple myelomas by suppressing interleukin-6 expression
1991 • 54 citations
Lymphokine induction of NK-like cytotoxicity in T cells from B-CLL
1986 • 46 citations
Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia
1991 • 40 citations
Inhibiting IL-6 in Human Multiple Myeloma
1992 • 37 citations
Interferon‐gamma interrupts autocrine growth mediated by endogenous interleukin‐6 in renal‐cell carcinoma
1991 • 24 citations
Response patterns of purified myeloma cells to hematopoietic growth factors
1989 • 19 citations
Molecular weight determination program
1984 • 10 citations